Literature DB >> 25257204

Comparative in vitro efficacies of various antipseudomonal antibiotics based catheter lock solutions on eradication of Pseudomonas aeruginosa biofilms.

Berna Ozbek1, Emel Mataraci-Kara1.   

Abstract

Antibiotic lock technique (ALT) may be an adjunct therapy in treating catheter-related infections. The aim of this study was to determine the in vitro stability and efficacy of colistin, meropenem and levofloxacin alone or in combination with clarithromycin or heparin lock solutions against biofilm embedded Pseudomonas aeruginosa strains. The efficacy of antibiotic lock solutions was tested in an in vitro catheter biofilm model against P. aeruginosa isolated from catheter-related bacteremia. We observed that the use of meropenem, levofloxacin or colistin as a lock solution had potent bactericidal effects and could be prevented bacterial regrowth at 96 or 72 hours, respectively. When the tested antibiotics were used in combination with clarithromycin, the combinations were significantly more effective and rapid in eliminating P. aeruginosa colonization in biofilm than each of the antibiotics were used alone. Moreover, tested antibiotics in combination with heparin were not significantly different for killing effect against PA-1 and PA-27853 compared with that of each antibiotics alone. Tested catheter lock solutions may have promising adjuvants for treating infections caused by P. aeruginosa.

Entities:  

Keywords:  Antipseudomonal agents; Catheter-related infections; Central venous catheter; Gram negative; Lock solution

Mesh:

Substances:

Year:  2016        PMID: 25257204     DOI: 10.1179/1973947814Y.0000000212

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  1 in total

Review 1.  Recent Advances in the Control of Clinically Important Biofilms.

Authors:  Katarzyna Krukiewicz; Alicja Kazek-Kęsik; Monika Brzychczy-Włoch; Marek J Łos; Collins Njie Ateba; Parvaneh Mehrbod; Saeid Ghavami; Divine Yufetar Shyntum
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.